Immun4Cure Cohort of Autoimmune Diseases
NCT07515638 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-04-15
Summary
This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.
Conditions
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Healthy Adult Volunteers
Interventions
- BIOLOGICAL
-
Blood test and principal collection
A total of 62.5 mL of blood will be collected while fasting, using the following tubes: * one 2.5 mL PAXGene Blood RNA Tube * seven 6mL heparinised Tubes * two 6mL EDTA Tubes * one 6mL dry Tube As part of routine care for groups 1, 2, and 3, and specific to research for group 4: A biological research assessment (urine and blood): complete blood count, platelets, HbA1c, reticulocytes, schizocytes, haptoglobin, ionogram, troponin, NT-proBNP, calcium, CRP, creatinine, GFR, uric acid, ferritin, CPK, fasting blood glucose, albumin, serum protein electrophoresis, total bilirubin, γGT, ASAT, ALAT, PAL, TSH, total cholesterol, LDL, HDL, triglycerides, B9, B12, HBV, HCV, HIV, CMV, EBV serology, antinuclear antibodies, DNA, ACPA, rheumatoid factor, C3, C4, proteinuria/creatininuria, urine strip test
- BIOLOGICAL
-
Optional collection
The optional collection will include: * stool sample (50 mL) * urine sample (50 mL) * saliva sample (2 mL)
- OTHER
-
Patient questionnaires
For groups 1 to 3 : Self-questionnaires will assess factors such as medical history, comorbidity exposure to toxic substances, occupational exposures, psychological and clinical factors. occupation and household income, as well as lifestyle habits (tobacco and alcohol consumption, possible drug use, sexual activity). Anxiety and depression environmental factors throughout life (diet, physical activity, sleep, contraception, sun exposure, pollution, noise, proximity to green spaces, etc.), 3-day food diary For group 4: Self-questionnaires will assess factors such comorbidity exposure to toxic substances, occupational exposures, psychological and clinical factors. occupation and household income, as well as lifestyle habits (tobacco and alcohol consumption, possible drug use, sexual activity). Anxiety and depression environmental factors throughout life (diet, physical activity, sleep, contraception, sun exposure, pollution, noise, proximity to green spaces, etc.), 3-day food diary
- OTHER
-
Examination
Group 1-RA: Capillaroscopy and optionnal Synovial microbiopsy Group 2-SLE: Optical coherence tomography (OCT) and optionnal skin biopsy and optionnal capillaroscopy Group 3-SSc: Capillaroscopy and optionnal skin biopsy Group 4: Optical coherence tomography (OCT) and capillaroscopie. Optionnal skin biopsy and optionnal Synovial microbiopsy
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Yves-Marie PERS, Pr · Montpellier University Hospital
-
Edouard TUAILLON, Pr · Montpellier University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2031-05-01
- Completion
- 2034-05-01
More Related Trials
-
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
NCT05961267 ·Status: COMPLETED
-
Catalytic Antibodies and Lupus in Martinique
NCT01157468 ·Status: COMPLETED
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Anti-nucleosome B Lymphocytes in Lupus
NCT01889654 ·Status: TERMINATED
-
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
NCT05193591 ·Status: RECRUITING
-
Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy
NCT05689463 ·Status: RECRUITING ·Phase: NA
-
Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus
NCT04894253 ·Status: TERMINATED
-
Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection
NCT07349823 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
NCT04844489 ·Status: COMPLETED ·Phase: NA
-
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
NCT06435468 ·Status: RECRUITING ·Phase: NA
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
NCT05866861 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
NCT04726553 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders
NCT07037732 ·Status: RECRUITING
-
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
NCT02891213 ·Status: UNKNOWN
-
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
NCT07134166 ·Status: NOT_YET_RECRUITING
-
Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
NCT06680310 ·Status: NOT_YET_RECRUITING
-
Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases
NCT06757426 ·Status: NOT_YET_RECRUITING
-
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
NCT06653556 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Analysis of B Cells From Autoimmune Individuals
NCT02747277 ·Status: COMPLETED
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
NCT03003572 ·Status: RECRUITING
-
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
NCT06379646 ·Status: RECRUITING ·Phase: NA
-
HLA Antibodies in Systemic Lupus Erythematosus
NCT06921239 ·Status: RECRUITING